Form 4 Tracker
Mayukh Sukhatme

Director, President & CIO · 7 filings · Latest: Sep 30, 2026

Roivant Sciences Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ROIV
Mayukh SukhatmeDirector, President & CIOJun 25, 2026
Sale
$34.13500,000$17.1M18,677,617
ROIV
Mayukh SukhatmeDirector, President & CIOJun 25, 2026
Option Exercise
$3.85500,000$1.9M19,177,617
ROIV
MAYUKH SUKHATME—Jun 26, 2026
Proposed Sale
$34.08500,000$17.0M—
ROIV
MAYUKH SUKHATME—Jun 25, 2026
Proposed Sale
$34.13500,000$17.1M—
ROIV
Mayukh SukhatmeDirector, President & CIOMar 30, 2026
Option Exercise
—58,391—18,894,938
ROIV
Mayukh SukhatmeDirector, President & CIOFeb 9, 2026
Sale
$26.47339,441$9.0M19,148,664
ROIV
Mayukh SukhatmeDirector, President & CIOFeb 9, 2026
Option Exercise
$12.68651,558$8.3M19,488,105
ROIV
Sukhatme Mayukh—Feb 9, 2026
Proposed Sale
$26.47339,441$9.0M—
ROIV
Sukhatme Mayukh—Dec 31, 2025
Proposed Sale
$21.711,018,995$22.1M—
ROIV
Sukhatme Mayukh—Dec 29, 2025
Proposed Sale
$21.74311,873$6.8M—
ROIV
Sukhatme Mayukh—Dec 17, 2025
Proposed Sale
$23.0926,831$619.5K—
ROIV
Sukhatme Mayukh—Dec 26, 2024
Proposed Sale
$12.01689,495$8.3M—
ROIV
Sukhatme Mayukh—Dec 24, 2024
Proposed Sale
$12.00185,946$2.2M—
ROIV
Sukhatme Mayukh—Dec 23, 2024
Proposed Sale
$12.0010,796$129.6K—
ROIV
Sukhatme Mayukh—Dec 18, 2024
Proposed Sale
$12.05412,584$5.0M—

← Previous

Page 2 of 2